The Current State of Opioid-Related Capabilities in Enterprise EHRs: Availability and Level of Technical Effort
Date
Mon, Sep 23, 2024, 05:00 AM
Digital Health Most Wired 2024 Trends Report is now available. Download Report
Date
Mon, Sep 23, 2024, 05:00 AM
The U.S. opioid overdose epidemic is one of the most significant public health crises of our time. Successfully addressing the problem requires a comprehensive and multi-faceted approach involving all levels of prevention, including working to reduce the incidence of opioid use disorder (OUD) through responsible prescribing of opioid pain medications, initiating OUD treatment with medication and counseling, and implementing harm reduction to prevent overdoses, morbidity, and mortality secondary to drug use. The enterprise electronic health record (EHR) system is an under-utilized critical tool in the fight.
Opioid-related capabilities available today in EHRs can save lives by preventing misuse, reducing (and more effectively treating) overdoses, and proactively decreasing the risk of opioid addiction. The CHIME Opioid Task Force (OTF) has identified 13 essential EHR capabilities that span five distinct categories: education, monitoring, alerts, prescribing support, and screening. We believe these are capabilities that every enterprise EHR vendor should offer – and that every hospital and health system should prioritize, implement, and provide training for.
CHIME OTF’s Thirteen Essential Opioid-Related EHR Capabilities (by Category)
Category | Capability |
---|---|
Education | Patient discharge summary to include opioid precautions and education when opioids are prescribed. |
Embedded on-line resources for clinical information. | |
Monitoring | Dashboard and analytics for opioid prescribing practices that allows for data to be segmented and analyzed by prescriber, dept, location, etc. |
Alerts | Alerts to co-prescribe Naloxone along with opioids and/or patients at high risk (e.g., post-OD). |
Alerts for patients on Benzodiazepines or other sedatives when prescribed opioids. | |
Reminders for providers to review PDMP (Prescription Drug Monitoring Program) when prescribing opioids. Reminders for providers to review opioid use agreements annually. | |
Prescribing Support | Morphine Milligram Equivalent (MME) calculator that presents in the patient's summary, alerts, and prescribing workflow. |
Templates for order set creation and maintenance that reflect best practices for opioid prescribing, including non-opioid options. | |
Clinical decision support that guides providers in proper prescribing of opioids and managing high risk patients. | |
Screening | Risk screening tools for patients with overdose or addiction history (e.g., Opioid Risk Tool, SOAPP, DAST). |
Tools/questionnaires that track or monitor function/pain levels for patients on opioids (e.g., PROMIS, PEG, DIRE). | |
Screening tools with clinical decision support to account for patient type (e.g., pediatric, maternal, neonatal populations) or by different settings (e.g., ER, inpatient, outpatient). |
Awareness and Degree of Difficulty Challenges
Maximizing the value of the EHR to combat the opioid overdose epidemic is essential. Clinical teams and IT leaders in your organization should be aware of all the pertinent capabilities available in your EHR – and then work together (along with your EHR vendor) to fully implement and configure that functionality so it can be correctly embedded in the right workflows.
Additionally, many of the capabilities listed in the table above require at least some degree of customization to produce the intended results. For example, your EHR system might have the ability to include opioid precautions and education in the patient discharge summary when opioids are prescribed, but is it automated to launch every time? Does the summary go to the right patient(s)?
Similarly, your EHR vendor may offer a dashboard for opioid prescribing practices, but is it usable and fully integrated? Does it show actionable information that clinicians can use to guide their decision making in real-time without leading to alert fatigue? The level of effort required from a technical customization and configuration perspective can vary widely depending on the type of functionality and the vendor’s approach.
Failure to implement and customize the 13 essential capabilities due to lack of awareness or coordination between clinical and IT stakeholders may have fatal consequences for patients. Given the importance of the functionality defined above and the urgency of the opioid crisis, the CHIME OTF surveyed three of the most-highly used EHR vendors to get a better understanding of 1) the scope of opioid-related functionality that is available in enterprise EHRs today, and 2) the level of effort required to implement those capabilities correctly from a technology perspective.
Survey Methodology
From May until Oct of 2023, the CHIME OTF conducted interviews with a representative from each EHR vendor who was intimately familiar with the opioid-related capabilities in their product. All follow-up questions and clarifications were addressed via email following the initial interviews. Each vendor provided a final data update in August 2024 to ensure the accuracy and relevance of the information at the time of publication.
The responses provided by the vendors represent a snapshot in time. Opioid-related capabilities in all three vendor solutions can and likely will evolve rapidly. The CHIME OTF acknowledges that “level of effort” is an inherently subjective term, and as such, the experience of individual organizations that implement these capabilities may vary. For each of the 13 capabilities listed, there are critical change management efforts that need to accompany the technical work. The score for “level of effort” in this survey self-reported by each vendor represents solely the technical effort required to customize and configure the functionality.
Findings
The results of the CHIME OTF’s survey serve as an important reminder about two key realities. Firstly, the level of effort needed for the technical customization and configuration of opioid-related functionality can vary. Work with your vendor and your IT/informatics team to maximize your unique workflow. Given the importance of these 13 essential capabilities as a whole, hospital and health system leaders need to account for the time and resources required so that all available capabilities are implemented correctly. If any capabilities listed above are not currently offered in your enterprise EHR, work with your vendor and IT team to establish a firm timeline of when your organization can expect to have them.
Secondly, vendors approach opioid-related capabilities differently. As such, the technical “degree of difficulty” – while relative – will vary from capability-to-capability and from vendor-to-vendor.
Underscoring these two key points, the survey specifically found:
Opioid-related capabilities available today in enterprise EHRs can save lives. However, getting the most out of the EHR’s massive potential to combat the opioid crisis requires that leaders across all areas of your organization have a strong understanding of what functionality is currently available and possible in the system. Your clinical and IT leaders must also know the level of technical effort required to correctly implement all 13 capabilities, and then work together – along with your core vendor – to ensure that functionality is customized in a way that maximizes informed decision-making. Success will also involve non-technical change management (e.g., cultural, and operational) that may be significantly more challenging than the technical effort required.
This survey regarding current opioid-related capabilities in leading EHR systems represents a snapshot in time. The opioid crisis is continuing to evolve, and technology needs to evolve accordingly. Functionality can change. Clinical and IT stakeholders in your organization must understand what is available in your EHR today – and the best ways to leverage that functionality – while also working closely with your vendor to understand their plans.
The 13 capabilities outlined in this article should be strongly considered. They are vital to fighting this devastating public health crisis and saving lives.
CHIME OTF’s Scoring of Each Vendor’s Opioid-Related Capabilities
Category | Capability | Vendor A | Vendor B | Vendor C |
---|---|---|---|---|
Education | Patient discharge summary to include opioid precautions and education when opioids are prescribed. | 3 | 2 | 2 |
Embedded on-line resources for clinical information. | 1 | 1 | 2 | |
Monitoring | Dashboard and analytics for opioid prescribing practices that allows for data to be segmented and analyzed by prescriber, dept, location, etc. | 1 | 2 | 2 |
Alerts | Alerts to co-prescribe Naloxone along with opioids and/or patients at high risk (e.g., post-OD). | 2 | 1 | 2 |
Alerts for patients on Benzodiazepines or other sedatives when prescribed opioids. | 2 | 2 | 2 | |
Reminders for providers to review PDMP (Prescription Drug Monitoring Program) when prescribing opioids. | 3 | 2 | 2 | |
Reminders for providers to review opioid use agreements annually. | 1 | 1 | 2 | |
Prescribing Support | Morphine Milligram Equivalent (MME) calculator that presents in the patient's summary, alerts, and prescribing workflow. | 2 | 1 | 2 |
Templates for order set creation and maintenance that reflect best practices for opioid prescribing, including non-opioid options. | 3 | 2 | 2 | |
Clinical decision support that guides providers in proper prescribing of opioids and managing high risk patients. | 3 | 2 | 3 | |
Screening | Risk screening tools for patients with overdose or addiction history (e.g., Opioid Risk Tool, SOAPP, DAST). | 4 | 2 | 2 |
Tools/questionnaires that track or monitor function/pain levels for patients on opioids (e.g., PROMIS, PEG, DIRE). | 1 | 1 | 1 | |
Screening tools with clinical decision support to account for patient tpe (e.g., pediatric, maternal, neonatal populations) or by different settings (e.g., ER, inpatient, outpatient). | 2 | 1 | 3 |
Key for degree of Difficulty
1) Little effort/pre-built | 2) Pre-built w/ customization | 3) More effort/expertise | 4) Requires vendor/future |
---|
Created by the CHIME Opioid Task Force Clinical Advisory subcommittee with special contributions from: Jason Fortin, Sean Kelly, MD, Patty Lavely, John Lee, MD, Greg Polston, MD, Jonathan Siff, MD, and Scott Weiner, MD, MPH.